Cellectar Biosciences CLRB
NASDAQ CLRB
$1.78 -0.09 (-4.81%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cellectar Biosciences (CLRB) Gains from Sales and Divestitures (2011 - 2021)

Updated

Cellectar Biosciences (CLRB) posted Gains from Sales and Divestitures of -$145,726 for FY2024.

Analysis

Cellectar Biosciences (CLRB) Gains from Sales and Divestitures (2011 - 2021) Analysis & Trends

Since FY2011, Cellectar Biosciences has reported Gains from Sales and Divestitures for 8 years.

  • The FY2024 figure stands as the lowest annual Gains from Sales and Divestitures in data going back to FY2011.
  • Business Quant data shows CLRB's Gains from Sales and Divestitures at -$3,386 in FY2022 and -$2,937 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cellectar Biosciences 21.77 Mn 21.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 1.00
Mar 31, 2021 -2,938.00
Dec 31, 2018 10,000.00
Dec 31, 2015 -583.00
Mar 31, 2015 -858.00
Sep 30, 2014 -1.00
Jun 30, 2014 1.00
Mar 31, 2014 -2,269.00
Dec 31, 2013 -3,010.00
Mar 31, 2013 -4,513.00
Sep 30, 2011 -6,009.00
API Access

Cellectar Biosciences Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CLRB&period=max&api_key=YOUR_API_KEY